Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Personalis, Inc.PSNL · Entity 4572 | President and CMO | September 18, 2026 | September 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Personalis, Inc.
Report date September 18, 2026 · Filed September 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 169,882 |
Reported balance
After 2026-09-18 transaction · row 1
1 source rowRow 1 · 2026-09-18 · Sale · Disposed 3,998 · Balance 169,882 F1: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 18, 2026 Filed Sep 22, 2026 20:10 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 3,998 | $16.22 | $64,847.56 |
DisclosureSEC source: 0001779787-26-000005 · form4-09222026_040906.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · President and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,882 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 01:27 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $2.44 | $0.00 |
DisclosureSEC source: 0001779787-26-000003 · form4-07162026_010735.xml · derivative · entry 3 Chen Richard · CIK 0001779787 · President and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2027-05-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 01:27 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 100,000 | $15.15 | $1,515,000.00 |
DisclosureSEC source: 0001779787-26-000003 · form4-07162026_010735.xml · nonDerivative · entry 2 Chen Richard · CIK 0001779787 · President and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 173,880 F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $15.01 to $15.45 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 01:27 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionCommon Stock | 100,000 | $2.44 | $244,000.00 |
DisclosureSEC source: 0001779787-26-000003 · form4-07162026_010735.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · President and CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 273,880 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 20:54 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantStock Option (right to buy) · Derivative | 281,250 | $0.00 Strike: $6.72 | $0.00 |
DisclosureSEC source: 0001779787-26-000002 · form4-03172026_080357.xml · derivative · entry 2 Chen Richard · CIK 0001779787 · President and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 281,250 Underlying: Common Stock · 281,250 shares Expires 2036-03-15 F3 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 15, 2026. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 20:54 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantCommon Stock | 46,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001779787-26-000002 · form4-03172026_080357.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · President and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,880 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest in 6 equal semi-annual installments with the first installment vesting on September 15, 2026. F2 · balance_after: Includes 2,500 shares acquired under the Issuer's Employee Stock Purchase Plan on October 31, 2025. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 23:50 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001779787-26-000001 · form4-02252026_110211.xml · derivative · entry 1 Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2034-03-15 F1 · balance_after: This amount represents the vesting of a performance stock option granted on March 15, 2024, following the satisfaction of a specified reimbursement milestone. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:20 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 452 | $6.57 | $2,969.64 |
DisclosureSEC source: 0001415889-25-020572 · form4-07302025_040703.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,505 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. Read SEC document |
| May 16, 2025 Filed May 20, 2025 21:50 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 910 | $4.95 | $4,504.50 |
DisclosureSEC source: 0001415889-25-013846 · form4-05202025_090557.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,957 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $4.85 to $5.05 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · balance_after: Includes 2,500 shares acquired under the Issuer's Employee Stock Purchase Plan on April 30, 2025. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 20:41 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantStock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $3.63 | $0.00 |
DisclosureSEC source: 0001415889-25-008415 · form4-03182025_080321.xml · derivative · entry 1 Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2035-03-15 F1 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 15, 2025. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 21:59 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 519 | $5.79 | $3,005.01 |
DisclosureSEC source: 0001415889-25-002386 · form4-01302025_090150.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,367 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:35 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 4,834 | $3.82 | $18,465.88 |
DisclosureSEC source: 0001415889-24-029741 · form4-12182024_041201.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,886 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $3.65 to $3.91 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| November 18, 2024 Filed Nov 20, 2024 21:14 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 921 | $3.79 | $3,490.59 |
DisclosureSEC source: 0001415889-24-027338 · form4-11202024_091153.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,720 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $3.76 to $3.79 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · balance_after: Includes 2,414 shares acquired under the Issuer's Employee Stock Purchase Plan on October 31, 2024. Read SEC document |
| July 30, 2024 Filed Aug 1, 2024 21:16 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 524 | $2.97 | $1,556.28 |
DisclosureSEC source: 0001415889-24-020534 · form4-08012024_090856.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,227 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $2.97 to $3.02 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 17, 2024 Filed Jun 20, 2024 20:55 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 5,055 | $1.29 | $6,520.95 |
DisclosureSEC source: 0001415889-24-017684 · form4-06202024_080625.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,751 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $1.26 to $1.29 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 17, 2024 Filed May 22, 2024 01:14 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 940 | $1.38 | $1,297.20 |
DisclosureSEC source: 0001415889-24-014041 · form4-05222024_010505.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,806 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $1.34 to $1.47 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · balance_after: Includes 4,876 shares acquired under the Issuer's Employee Stock Purchase Plan on April 30, 2024. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 20:30 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantStock Option (right to buy) · Derivative | 175,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001415889-24-008530 · form4-03192024_040309.xml · derivative · entry 1 Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2034-03-15 F1 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 15, 2024. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 21:30 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 526 | $1.37 | $720.62 |
DisclosureSEC source: 0001415889-24-002075 · form4-01312024_090126.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,870 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. Read SEC document |
| December 15, 2023 Filed Dec 19, 2023 23:09 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 4,708 | $1.47 | $6,920.76 |
DisclosureSEC source: 0001209191-23-059243 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer and EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,396 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. F2 · balance_after: Includes 5,000 shares acquired under the Issuer's Employee Stock Purchase Plan ("ESPP") on April 28, 2023 and 5,000 shares acquired under the Issuer's ESPP on October 31, 2023. Read SEC document |
| November 16, 2023 Filed Nov 20, 2023 21:30 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 940 | $1.04 | $977.60 |
DisclosureSEC source: 0001209191-23-056065 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer and EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,104 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. Read SEC document |
| July 31, 2023 Filed Aug 2, 2023 20:20 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 485 | $2.26 | $1,096.10 |
DisclosureSEC source: 0001209191-23-044216 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer and EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,044 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. Read SEC document |
| June 16, 2023 Filed Jun 21, 2023 20:51 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 4,817 | $2.07 | $9,971.19 |
DisclosureSEC source: 0001209191-23-038813 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer and EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,529 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. Read SEC document |
| May 17, 2023 Filed May 19, 2023 21:37 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 971 | $1.98 | $1,922.58 |
DisclosureSEC source: 0001209191-23-031168 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer and EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,346 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 21:57 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 1,314 | $2.83 | $3,718.62 |
DisclosureSEC source: 0001209191-23-020372 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer and EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,317 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 22:16 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantStock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $2.76 | $0.00 |
DisclosureSEC source: 0001209191-23-019877 · doc4.xml · derivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2033-03-15 F1 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 15, 2023. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 22:09 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 562 | $2.20 | $1,236.40 |
DisclosureSEC source: 0001209191-23-006269 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,631 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| December 20, 2022 Filed Dec 22, 2022 22:03 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 1,750 | $1.92 | $3,360.00 |
DisclosureSEC source: 0001209191-22-062465 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,193 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 21:23 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 7,177 | $2.50 | $17,942.50 |
DisclosureSEC source: 0001209191-22-061900 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,943 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 21:50 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 440 | $2.60 | $1,144.00 |
DisclosureSEC source: 0001209191-22-060025 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,120 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| November 16, 2022 Filed Nov 18, 2022 22:02 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 1,295 | $2.71 | $3,509.45 |
DisclosureSEC source: 0001209191-22-057904 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,560 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| September 20, 2022 Filed Sep 22, 2022 20:13 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 1,581 | $3.48 | $5,501.88 |
DisclosureSEC source: 0001209191-22-051013 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,855 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| September 02, 2022 Filed Sep 8, 2022 20:18 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 420 | $3.33 | $1,398.60 |
DisclosureSEC source: 0001209191-22-049154 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,436 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 21:00 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantStock Option (right to buy) · Derivative | 29,890 | $0.00 Strike: $5.32 | $0.00 |
DisclosureSEC source: 0001209191-22-046339 · doc4.xml · derivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,890 Underlying: Common Stock · 29,890 shares Expires 2032-08-15 F1 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vested on June 15, 2022. Read SEC document |
| July 28, 2022 Filed Aug 1, 2022 22:12 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 632 | $3.91 | $2,471.12 |
DisclosureSEC source: 0001209191-22-043733 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,856 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| June 17, 2022 Filed Jun 21, 2022 20:52 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 1,565 | $3.29 | $5,148.85 |
DisclosureSEC source: 0001209191-22-038445 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,488 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 21:08 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 6,818 | $3.24 | $22,090.32 |
DisclosureSEC source: 0001209191-22-037962 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,053 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 21:30 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 421 | $3.59 | $1,511.39 |
DisclosureSEC source: 0001209191-22-034599 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,871 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. F2 · balance_after: This reflects a reduction of 538 shares due to a scrivener's error on the reporting person's prior filings and does not indicate a purchase and/or sale of such shares. Read SEC document |
| May 16, 2022 Filed May 18, 2022 22:14 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 1,286 | $4.86 | $6,249.96 |
DisclosureSEC source: 0001209191-22-030218 · doc4.xml · nonDerivative · entry 2 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,830 F2 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. F3 · balance_after: This reflects a reduction of 538 shares due to a scrivener's error on the reporting person's prior filing and does not indicate a purchase and/or sale of such shares. Read SEC document |
| April 29, 2022 Filed May 18, 2022 22:14 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantCommon Stock | 1,558 | $4.76 | $7,416.08 |
DisclosureSEC source: 0001209191-22-030218 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,116 F1 · shares: Includes 1,558 shares acquired under the Issuer's Employee Stock Purchase Plan dated April 29, 2022. Read SEC document |
| March 17, 2022 Filed Mar 22, 2022 00:41 UTC | Personalis, Inc. PSNL · Entity 4572 | Disposition to issuerCommon Stock | 1,776 | $7.98 | $14,172.48 |
DisclosureSEC source: 0001209191-22-020418 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,558 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 23:09 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 471 | $10.18 | $4,794.78 |
DisclosureSEC source: 0001209191-22-016451 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,334 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| January 28, 2022 Filed Feb 1, 2022 23:05 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 705 | $9.93 | $7,000.65 |
DisclosureSEC source: 0001209191-22-006005 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,805 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| December 17, 2021 Filed Dec 21, 2021 00:10 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 1,563 | $12.80 | $20,006.40 |
DisclosureSEC source: 0001209191-21-070654 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,510 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 22:14 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantCommon Stock | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070009 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,073 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs shall vest in semi-annual installments over three years with the first installment of 13,333 RSUs vesting on June 14, 2022. Read SEC document |
| December 02, 2021 Filed Dec 6, 2021 23:06 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 419 | $12.92 | $5,413.48 |
DisclosureSEC source: 0001209191-21-068173 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,073 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 23:12 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 1,253 | $17.04 | $21,351.12 |
DisclosureSEC source: 0001209191-21-065916 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,781 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| October 29, 2021 Filed Nov 19, 2021 23:12 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantCommon Stock | 711 | $16.68 | $11,859.48 |
DisclosureSEC source: 0001209191-21-065916 · doc4.xml · nonDerivative · entry 2 Chen Richard · CIK 0001779787 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,492 F2 · shares: These Shares are being voluntarily reported on this Form 4 to report the acquisition by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| September 17, 2021 Filed Sep 21, 2021 22:35 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 1,088 | $21.25 | $23,120.00 |
DisclosureSEC source: 0001209191-21-057100 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,034 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| September 02, 2021 Filed Sep 7, 2021 21:50 UTC | Personalis, Inc. PSNL · Entity 4572 | SaleCommon Stock | 291 | $21.92 | $6,378.72 |
DisclosureSEC source: 0001209191-21-055046 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,122 F1 · shares: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 21:19 UTC | Personalis, Inc. PSNL · Entity 4572 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,946 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001209191-21-050648 · doc4.xml · derivative · entry 5 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,946 shares Expires 2022-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The Shares subject to the option are fully vested and exercisable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.